Acro Biomedical Co Stock Probability of Future Pink Sheet Price Finishing Over 7.0E-4

ACBM Stock  USD 0.0007  0.00  0.00%   
ACRO Biomedical's future price is the expected price of ACRO Biomedical instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of ACRO Biomedical Co performance during a given time horizon utilizing its historical volatility. Check out ACRO Biomedical Backtesting, ACRO Biomedical Valuation, ACRO Biomedical Correlation, ACRO Biomedical Hype Analysis, ACRO Biomedical Volatility, ACRO Biomedical History as well as ACRO Biomedical Performance.
  
Please specify ACRO Biomedical's target price for which you would like ACRO Biomedical odds to be computed.

ACRO Biomedical Target Price Odds to finish over 7.0E-4

The tendency of ACRO Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 0.0007 90 days 0.0007 
about 85.38
Based on a normal probability distribution, the odds of ACRO Biomedical to move above the current price in 90 days from now is about 85.38 (This ACRO Biomedical Co probability density function shows the probability of ACRO Pink Sheet to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days ACRO Biomedical has a beta of 0.65. This suggests as returns on the market go up, ACRO Biomedical average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding ACRO Biomedical Co will be expected to be much smaller as well. Additionally ACRO Biomedical Co has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   ACRO Biomedical Price Density   
       Price  

Predictive Modules for ACRO Biomedical

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as ACRO Biomedical. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.000.00083.84
Details
Intrinsic
Valuation
LowRealHigh
0.000.00073.84
Details
Naive
Forecast
LowNextHigh
0.0000120.00063.84
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.00070.00070.0007
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as ACRO Biomedical. Your research has to be compared to or analyzed against ACRO Biomedical's peers to derive any actionable benefits. When done correctly, ACRO Biomedical's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in ACRO Biomedical.

ACRO Biomedical Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. ACRO Biomedical is not an exception. The market had few large corrections towards the ACRO Biomedical's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold ACRO Biomedical Co, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of ACRO Biomedical within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.55
β
Beta against Dow Jones0.65
σ
Overall volatility
0.0002
Ir
Information ratio -0.16

ACRO Biomedical Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of ACRO Biomedical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for ACRO Biomedical can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
ACRO Biomedical generated a negative expected return over the last 90 days
ACRO Biomedical has some characteristics of a very speculative penny stock
ACRO Biomedical has high historical volatility and very poor performance
ACRO Biomedical has high likelihood to experience some financial distress in the next 2 years
About 50.0% of the company shares are held by company insiders

ACRO Biomedical Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of ACRO Pink Sheet often depends not only on the future outlook of the current and potential ACRO Biomedical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. ACRO Biomedical's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding47.8 M
Cash And Short Term Investments95.2 K

ACRO Biomedical Technical Analysis

ACRO Biomedical's future price can be derived by breaking down and analyzing its technical indicators over time. ACRO Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of ACRO Biomedical Co. In general, you should focus on analyzing ACRO Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.

ACRO Biomedical Predictive Forecast Models

ACRO Biomedical's time-series forecasting models is one of many ACRO Biomedical's pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary ACRO Biomedical's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.

Things to note about ACRO Biomedical

Checking the ongoing alerts about ACRO Biomedical for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for ACRO Biomedical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
ACRO Biomedical generated a negative expected return over the last 90 days
ACRO Biomedical has some characteristics of a very speculative penny stock
ACRO Biomedical has high historical volatility and very poor performance
ACRO Biomedical has high likelihood to experience some financial distress in the next 2 years
About 50.0% of the company shares are held by company insiders

Other Information on Investing in ACRO Pink Sheet

ACRO Biomedical financial ratios help investors to determine whether ACRO Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ACRO with respect to the benefits of owning ACRO Biomedical security.